Hoya Vision Care showcased new research, clinical education initiatives, and real-world evidence in myopia management during the 17th Annual European Academy of Optometry and Optics (EAOO) conference, held May 15-17 in Riga, Latvia.

The company presented seven scientific papers, four posters, a hands-on workshop, and an educational lecture during the conference, while also announcing the Europe, Middle East, and Africa (EMEA) winner of its “Clinical Excellence in Myopia Management” MiYOSMART Case Study Contest. The activities followed the recent presentation of 12-month randomized controlled trial findings for MiYOSMART iQ at ARVO 2026, where researchers reported that 9 out of 10 children experienced no clinically relevant myopia progression during the first year of wear.¹˒²

The contest invited eye care professionals (ECPs) to submit patient cases involving MiYOSMART spectacle lenses in complex clinical settings, with the aim of fostering discussion around practical treatment approaches and contributing to a growing body of real-world evidence.

Three finalists were selected from submissions spanning 30 countries across the EMEA region: Dr. Stephanie Kearney of the United Kingdom, Dr. Vitaliya Zhurba of Kazakhstan, and Marion Wolff of France. 

Marion Wolff of Kirchberg Ophthalmology in Greater Strasbourg was named this year’s winner for presenting a 5-year clinical follow-up involving a young patient treated during the critical 8-to-12-year age window and with a strong family history of myopia.

As part of its educational programming, Hoya Vision Care also conducted a hands-on workshop introducing Hoyalux iD MySense, the company’s latest personalized progressive addition lens (PAL) technology. Delegates received practical experience using visuSense, Hoya’s measurement platform designed to assess each patient’s “Visual Sensory Intelligence” and optimize PAL customization.

Professor Fabrizio Zeri presented additional research examining adaptation outcomes among successful and unsuccessful progressive lens wearers.³

References

  1. Tse DYY, et al. Myopia Control Efficacy of Defocus Incorporated Multiple Segments Spectacle Lens with Triple Enhanced Design: a 12-month randomized controlled trial. Presented at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting, May 3–7, 2026. Abstract 2523. Available at: https://eppro02.ativ.me/web/index.php?page=IntHtml&project=ARVO26&id=4486941. Accessed May 18, 2026.
  2. Hoya data on file. Hoya MiYOSMART iQ spectacle lens clinical outcomes. April 2026.
  3. Zeri F, et al. Adaptation outcomes with progressive addition spectacle lenses in previously successful and unsuccessful wearers. Presented at the 17th Annual European Academy of Optometry and Optics (EAOO) Conference, May 15–17, 2026, Riga, Latvia.
  4. Montani G, et al. Effect of Blue Light Attenuator Lenses on Visual Comfort, Visual Functions and Digital Eye Strain Symptoms. Presented at the 17th Annual European Academy of Optometry and Optics (EAOO) Conference, May 15–17, 2026, Riga, Latvia.